APR said on the 22nd that its beauty device brand "Medicube Age-R (AGE-R)" had reached 5 million units in cumulative global sales as of last month. It took about 4 years and 6 months since the launch of its first product, "Derma EMS Shot," in March 2021.
APR completed the internalization of the beauty device value chain covering the entire process of "planning–research and development–production–distribution," a first among domestic beauty corporations, by starting operation of its own manufacturing plant, "APR Factory," with the launch of "Booster Pro" in Oct. 2023. Through this, it strengthened product quality and production efficiency and accelerated its expansion into global markets based on a stable supply chain.
Since then, it has continued to expand its lineup — ▲ Ultra Tune 40.68 ▲ High Focus Shot ▲ Booster Pro Mini ▲ Booster Vibration Cleanser ▲ Booster Pro Mini Plus ▲ High Focus Shot Plus — improving customer satisfaction. The flagship product, "Booster Pro," surpassed 2 million units in cumulative global sales, driving overall brand growth.
It is also showing notable performance in overseas markets. Of the 5 million units in cumulative global sales of Age-R devices, the overseas sales share has exceeded half, with especially clear growth in the United States and Japan.
An Age-R official said, "We achieved meaningful results by carrying out the entire process from beauty device planning to production and sales in-house and securing quality competitiveness," and added, "We will continue to grow into a leading K-beauty corporations trusted in the global market based on innovative technology and safety."